Antiviral Therapies
Through collaborations with an extensive network of companies within the fields of (bio)pharmaceuticals and molecular testing, we have developed antiviral therapies for viruses such as:
● HBV
● HCV
● RSV
● Rhinovirus
● Influenza
● VZV
● CMV
● SARS-CoV-2
Apart from antiviral testing, we offer analysis solutions for bacterial strains through microbiome analysis with 16S rDNA methodology to enhance the clinical development of antibacterial therapies.